(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $210 | |||
Short term investments | $44 | |||
Net receivables | $196 | |||
Inventory | ||||
Total current assets | $450 | |||
Long term investments | $950 | |||
Property, plant & equipment | $63 | |||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1400 | |||
Current liabilities | ||||
Accounts payable | $17 | |||
Deferred revenue | ||||
Short long term debt | $150 | |||
Total current liabilities | $508 | |||
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $575 | |||
Shareholders' equity | ||||
Retained earnings | -$2102 | |||
Other shareholder equity | -$14 | |||
Total shareholder equity | $825 |
(in millions $) | 31 Jan 2025 | 31 Jan 2024 | 28 Mar 2023 | 31 Dec 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $426 | $214 | ||
Short term investments | $182 | $334 | ||
Net receivables | $135 | $217 | ||
Inventory | ||||
Total current assets | $743 | $1006 | ||
Long term investments | $936 | $30 | ||
Property, plant & equipment | $69 | $48 | ||
Goodwill & intangible assets | ||||
Total noncurrent assets | $1812 | |||
Total investments | ||||
Total assets | $1679 | $2818 | ||
Current liabilities | ||||
Accounts payable | $24 | $20 | ||
Deferred revenue | $225 | |||
Short long term debt | $367 | |||
Total current liabilities | $729 | $429 | ||
Long term debt | $720 | |||
Total noncurrent liabilities | $885 | |||
Total debt | ||||
Total liabilities | $822 | $1314 | ||
Shareholders' equity | ||||
Retained earnings | -$2028 | -$1306 | ||
Other shareholder equity | -$18 | -$13 | ||
Total shareholder equity | $857 | $1556 |
(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 30 Dec 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $175 | |||
Cost of revenue | ||||
Gross Profit | $127 | |||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $118 | |||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $15 | |||
Interest expense | $5 | |||
Net income | ||||
Net income | -$21 | |||
Income (for common shares) |
(in millions $) | 31 Jan 2023 | 28 Mar 2022 | 27 Feb 2021 | 28 Feb 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $893 | $1040 | ||
Cost of revenue | $250 | $272 | ||
Gross Profit | $643 | $768 | ||
Operating activities | ||||
Research & development | $215 | $259 | ||
Selling, general & administrative | $342 | $519 | ||
Total operating expenses | $989 | $1244 | ||
Operating income | -$96 | -$204 | ||
Income from continuing operations | ||||
EBIT | -$96 | -$204 | ||
Income tax expense | -$9 | $4 | ||
Interest expense | -$15 | -$23 | ||
Net income | ||||
Net income | -$1104 | -$152 | ||
Income (for common shares) | -$1104 | -$152 |
(in millions $) | 30 Dec 2023 | 1 Oct 2023 | 1 Jul 2023 | 28 Mar 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $112 | $76 | -$38 | $176 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$211 | $2 | $2 | $6 |
Effect of exchange rate | -$3 | |||
Change in cash and equivalents | -$87 | $121 | $63 | -$84 |
(in millions $) | 28 Mar 2023 | 27 Feb 2022 | 27 Feb 2021 | 28 Feb 2020 |
---|---|---|---|---|
Net income | $12 | -$1104 | -$152 | |
Operating activities | ||||
Depreciation | $176 | $198 | $212 | |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$28 | $82 | $26 | |
Investing activities | ||||
Capital expenditures | -$8 | -$8 | -$12 | |
Investments | $222 | $3 | -$145 | |
Total cash flows from investing | $176 | $207 | -$65 | -$188 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -$246 | -$2 | ||
Total cash flows from financing | $6 | $10 | -$227 | $7 |
Effect of exchange rate | -$3 | -$1 | $2 | -$1 |
Change in cash and equivalents | -$84 | $188 | -$208 | -$156 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |